| Pharmaceutical active ingredients: |
| Gadofosveset Trisodium |
| Available forms, composition and doses of Ablavar: |
| Injectable; Injection; Gadofosveset Trisodium 244 mg / ml |
| Ablavar medical category: |
| Human:Diagnostics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| V08CA11 - Gadofosveset |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Lantheus Medical Imaging |
| Related documents and information about Ablavar: |
| Ablavar prescribing information (PDF) |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Gadavist | Gadobutrol | Bayer Schering Pharma |
| Gadograf | Gadobutrol | Juste Quimico-Farmaceutica |
| Gadovist | Gadobutrol | Bayer Schering Pharma; Berlex Laboratories |
| Omniscan | Gadodiamide | Amersham; GE Healthcare; Medison Pharma; Nycomed; Sankyo; Sanofi-Aventis |
| Onmiscan | Gadodiamide | GE Healthcare |
| Vasovist | Gadofosveset Trisodium | Bayer Schering Pharma; Epix |
| Gadomin | Gadopentetate Dimeglumine | Shanghai Xudong Haipu Pharmaceutical; Endure Medical |
| Magnetol | Gadopentetate Dimeglumine | Soreq Nuclear Research Center |
| Magnevist | Gadopentetate Dimeglumine | Bayer Schering Pharma; Berlex Laboratories; Hospira |
| Magnevist 2 | Gadopentetate Dimeglumine | Bayer Schering Pharma |